Who Owns KALA BIO Stock?
NASDAQ: KALAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 9, 10:47 AM ET
Ownership breakdown
- Held by institutions
- 4.07%
- Held by insiders
- 1.24%
- Institutional holders
- 24
- Institutions 4.1%
- Insiders 1.2%
- Public and other 94.7%
Who owns KALA BIO stock?
Institutional investors own about 4.1% of KALA BIO's shares, spread across 24 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 1.24% of KALA.
The largest institutional holders are Vanguard Capital Management LLC (1.14%), Geode Capital Management, LLC (0.75%) and Vanguard Fiduciary Trust Co (0.52%). Together, the top 10 institutions control 3.6% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their KALA positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of KALA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 220.62K | 1.14% | +18118.3% |
| Geode Capital Management, LLC | 145.15K | 0.75% | +2680.2% |
| Vanguard Fiduciary Trust Co | 101.40K | 0.52% | +16998.8% |
| State Street Corporation | 88.57K | 0.46% | +15384.3% |
| Blackrock Inc. | 71.54K | 0.37% | +33021.3% |
| Northern Trust Corporation | 41.61K | 0.22% | +17989.6% |
| Qube Research & Technologies Ltd | 11.07K | 0.06% | +100.0% |
| Goldman Sachs Group Inc | 10.92K | 0.06% | +3786.5% |
| UBS Group AG | 9.06K | 0.05% | +577.4% |
| Tower Research Capital LLC (TRC) | 616 | 0.00% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of KALA
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 220.62K | 1.14% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 96.49K | 0.50% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 19.20K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 17.40K | 0.09% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 12.83K | 0.07% |
| John Hancock Variable Insurance Trust-Total Stock Market Index Trust | 355 | 0.00% |
Frequently asked questions
Who is the largest shareholder of KALA BIO?
Vanguard Capital Management LLC is the largest institutional shareholder of KALA, owning 1.14% of shares outstanding (220.62K shares) as of its latest 13F filing.
What percentage of KALA BIO is owned by institutions?
Institutions own about 4.1% of KALA shares and 4.1% of the public float.
How much of KALA BIO do insiders own?
Insiders, such as officers and directors, own about 1.24% of KALA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.